Internet search for information about the Coalition leads to the SR website. 1 Given all that is already going on in defence of animal research, including many existing associations of associations, it is not clear why a new coalition was considered necessary.
UAR aims "to achieve a broad understanding of the humane use of animals in medical, veterinary, scientific and environmental research in the UK", 2 "based on thorough research and understanding of the facts, historical and scientific". EARA "advocates biomedical research using animals by providing accurate and evidence-based information", 3 and the aim of SR is to provide "accurate information about the importance of animal research/ animal testing in medical and veterinary science". 4 Care has to be taken in looking for news of EARA, since the acronym can also mean other things, including the European Association for Research on Adolescence (EARA), Environmental Auditors Registration Association (EARA), and Evaluation & Active Research Associates (EARA). The EARA to which we refer here was set up in 2014, and its Director is Kirk Leech. Its activities include a Science Action Network, initially established by UAR, "which aims to debunk animal rights misinformation". 5 SR was formed by Tom Holder in 2008, inspired by the UK student Pro-Test movement, which led to the establishment of groups with the same aim in Germany, Italy and the USA. 6 It appears to operate mainly via its news blog, which aims "to share news and information about animal-based research, but also to create and promote opportunities for dynamic exchanges between people who hold a wide-range of views about the topic". 7 UAR, a phoenix which arose from the ashes of the Research Defence Society, is responsible for the Concordat on Openness in Animal Research in the UK, which recently published its 48-page 2016 Report. No detailed comments about the report will be made here, but in its Foreword, Geoff Watts, Chair of the Concordat Steering Group, referring to the "welcome decline in violent extremism targeted at the research community", said: "The time to build defences against some future upsurge of suspicion about research involving animals is before such suspicion erupts. With public antagonism at what seems to be a relatively low level, that time is now. Only when the use of animals in science is seen as a necessity by an even greater majority of the public can we count on the wholehearted support of that public, should it be needed." 8 Whether or not these organisations and their Consortium live up to their stated ambitions is a matter of judgement, based on consideration of what they actually do. As in many other situations with which we are faced in the complex world in which we now live, the main problem is the uneasy relationship between "accurate information" and biased propaganda. A short time spent on the websites of the above organisations is not an ideal way to discover the facts about the extent to which animal procedures can/cannot be considered to be "necessary" in biomedical research and safety testing.
It was proposed in a recent ATLA Editorial that the combatants in the ongoing propaganda war about animal experimentation should search together for the truth (i.e. for information in accordance with fact and reality). 9 However, the indisputable and inescapable fact is that the numbers of animal experiments are not declining -in fact,
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As a new consortium to promote animal experimentation is formed, the numbers of procedures reported to the UK Home Office continue to increase, and opportunities to replace them are not being taken the number of animal procedures conducted in the UK increased again in 2015. 10 This is despite all the claims, from across the spectrum of views, of commitment to the Three Rs. It is also despite the now vast amount of effort being put into the search for scientifically more-advanced and more-relevant methods to take over from the use of animal procedures that are inadequate and invalid as a result of the need for species-species extrapolation and, often, the lack of a relevant mechanistic basis.
One matter, which should be of great concern to all those truly committed to the Three Rs -including the members of the latest Coalition and the Concordat, as well as scientists, industries, politicians and governments -is that, where replacement alternatives do already exist, they are not necessarily being used. In her review of the 2015 UK Statistics, 11 Michelle Hudson-Shore voices concern about the lack of use of non-animal methods for regulatory procedures, giving the examples of pyrogenicity testing and antibody production. She also mentions concerns about botulinum toxin testing and testing for skin and eye irritation.
To investigate this issue further, we read the 19 non-technical lay summaries of projects for which licences for regulatory studies were issued by the Home Office in 2015, for the application of regulatory procedures on laboratory animals 12 . Of these, two involved antibody production, and six involved some form of safety testing, including safety pharmacology. These summaries are now presented in tabular format, with no references or other data supporting the statements made, although we assume that establishments are still required to provide evidence that a search has been conducted to confirm the absence of suitable non-animal alternative methods. Instead, each of the non-technical summaries merely includes a response to: "State why you need to use animals and why you cannot use non-animal alternatives."
Of the two projects on antibody production, one was for polyclonal antibodies, for which the response to the above was: "Currently there are no methods available for the production of specific polyclonal antibodies using non-animal alternatives." Likewise, for the other project, which required testing vaccines on chickens challenged with a virus, the response was: "Non animal based systems are not available for the production of all chicken viruses..." Similarly, in the case of the projects for regulatory safety testing, unsupported arguments were often used, but with certain caveats. Two of the project summaries indicated when alternatives would be used, for example: "Alternatives have been introduced for skin tests and eye tests and are used. That is why there is no skin and eye testing [on animals] for irritancy included in this project".
It is clear that, except where the use of animals for certain forms of testing has been banned, such as for tobacco, cosmetics and household products, the demand by regulatory bodies for animal tests to satisfy safety requirements is widely used in the summaries as a rationale for testing in the first place, and also for justification for seeking permission to use animals. Good illustrations of the latter are: "Working with animals is only where specifically stipulated by regulatory requirements or for the production of antisera required for the in vitro tests required by pharmacopoeias and/or marketing authorisations..." and: "Current regulatory guidelines indicate the need for conduct of both non-animal methods and those which use animals, in this field of regulatory work."
The above reflects the fact that regulatory toxicity testing is, in effect, accorded special status by the Home Office. This means that the normal procedure used for fundamental research and applied studies, which are assessed for project licences individually, on a case-by-case basis, does not apply. Elsewhere, 13 we have discussed the causes and consequences of what is known as 'bulk project licence authorisation', whereby a blanket licence is issued for the regulatory testing of a wide range of materials. This is beneficial to the licensee, as it eliminates the need for a number of separate project applications. The policy also gives greater flexibility to companies in either bidding for work, contracting out, or undertaking work in-house, when they have to satisfy regulatory authorities abroad.
However, we cannot support this long-standing policy, because it is incompatible with the fundamental basis for assessing animal experimentation, namely, the cost-benefit analysis. This weighs the benefits of a study, and the likelihood that they will arise, against the welfare costs to the animals. The benefits should be judged by analysing each test material/product individually, not collectively. In addition, the need for regulatory testing per se should neither be considered as a benefit, nor invoked to decide, on the basis of regulatory acceptability, whether a non-animal test is 'reasonably and practicably available', and therefore, should or should not be used instead of the corresponding animal test. This is because that is ethically inconsistent, and it should not be up to regulatory bodies to veto legislation, since they may be either unaware of, or slow to react to, developments in relation to alternative test methods.
In 2007, we wrote: 13 "[the cost-benefit assessment] ...should depend, not only on the toxicity test being conducted and the species being used in relation to the identification of a particular hazard, but also on the substance being tested and the specific benefits." We still hold these views because they are consistent with the premise that testing, which is deemed intrinsically unethical for various reasons -such as being rejected by applying the same cost-benefit analysis as used for fundamen-tal research -suddenly cannot become ethical, merely as a result of a consideration of commercial interests. Such considerations should be discussed separately with the relevant authority. Moreover, our views are also consistent with the concept of the Home Office banning certain testing on the basis of either the species and/or the products involved. This is because it is illogical not to require individual cost-benefit analyses for products, if their testing on animals has not been banned.
Hudson-Shore's own words 11 provide a fitting conclusion to our comments: "The examples of currently available non-animal replacements for regulatory animal tests that are not being fully utilised, provide impetus to call legislators and companies to account. They must ensure that regulatory requirements are being enforced and that the European laws are being adhered to. These legislators and companies are encouraged to do more to ensure the widespread dissemination and implementation of the particular methods discussed in this paper, and to do more to speed up the acceptance and integration of non-animal methods into harmonised legislative frameworks." 
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